Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation
- 1 June 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (12) , 1279-1283
- https://doi.org/10.1038/sj.bmt.1702424
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 8 references indexed in Scilit:
- Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiationBone Marrow Transplantation, 1999
- Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesisAnnals of Oncology, 1994
- Improved Control of Emesis and Quality of Life with Ondansetron in Breast CancerOncology, 1993
- A Review of Ondansetron in the Management of Radiotherapy-Induced EmesisOncology, 1993
- Intravenous granisetron — establishing the optimal doseEuropean Journal Of Cancer, 1992
- Advances in the control of chemotherapy-induced emesisAnnals of Oncology, 1992
- GranisetronDrugs, 1991
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983